The anxiolytic effects of atorvastatin and simvastatin on dietary-induced increase in homocysteine levels in rats

[1]  K. Li,et al.  Neuroproteomics , 2020, Neuromethods.

[2]  S. Lu,et al.  S-Adenosylmethionine. , 2020, The international journal of biochemistry & cell biology.

[3]  I. Zaletel,et al.  The opposite effects of nandrolone decanoate and exercise on anxiety levels in rats may involve alterations in hippocampal parvalbumin–positive interneurons , 2017, PloS one.

[4]  Xinyu Zhang,et al.  Simvastatin ameliorates cognitive impairments via inhibition of oxidative stress‑induced apoptosis of hippocampal cells through the ERK/AKT signaling pathway in a rat model of senile dementia. , 2017, Molecular medicine reports.

[5]  H. Chiou,et al.  Associations between serum homocysteine levels and anxiety and depression among children and adolescents in Taiwan , 2017, Scientific Reports.

[6]  V. Jakovljevic,et al.  The Beneficial Effects of Sulfur-containing Amino Acids on Cisplatininduced Cardiotoxicity and Neurotoxicity in Rodents. , 2017, Current medicinal chemistry.

[7]  E. Halasová,et al.  International Journal of Molecular Sciences the Molecular and Cellular Effect of Homocysteine Metabolism Imbalance on Human Health , 2022 .

[8]  D. Obradović,et al.  The adverse effects of exercise and supraphysiological dose of testosterone-enanthate (TE) on exploratory activity in elevated plus maze (EPM) test - indications for using total exploratory activity (TEA) as a new parameter for ex. , 2016, Neuro endocrinology letters.

[9]  D. Djuric,et al.  Anxiety-related behavior in hyperhomocysteinemia induced by methionine nutritional overload in rats: role of the brain oxidative stress. , 2016, Canadian journal of physiology and pharmacology.

[10]  Paul C. D. Johnson,et al.  High Dose Atorvastatin Associated with Increased Risk of Significant Hepatotoxicity in Comparison to Simvastatin in UK GPRD Cohort , 2016, PloS one.

[11]  M. Elbatsh.  Antidepressant-like effect of simvastatin in diabetic rats. , 2015, Canadian journal of physiology and pharmacology.

[12]  A. Tufan,et al.  Vitamin B12, folate, and homocysteine levels in patients with obsessive–compulsive disorder , 2014, Neuropsychiatric disease and treatment.

[13]  Tsu-Kung Lin,et al.  Simvastatin treatment exerts antidepressant-like effect in rats exposed to chronic mild stress , 2014, Pharmacology Biochemistry and Behavior.

[14]  R. Citraro,et al.  Protective effects of some statins on epileptogenesis and depressive‐like behavior in WAG/Rij rats, a genetic animal model of absence epilepsy , 2014, Epilepsia.

[15]  C. Funchal,et al.  Antioxidant Activity of Grapevine Leaf Extracts against Oxidative Stress Induced by Carbon Tetrachloride in Cerebral Cortex, Hippocampus and Cerebellum of Rats , 2014, Antioxidants.

[16]  D. Dobrota,et al.  Hyperhomocysteinemia as a risk factor for the neuronal system disorders. , 2014, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[17]  Xiping Xu,et al.  Effect of simvastatin on plasma homocysteine levels and its modification by MTHFR C677T polymorphism in Chinese patients with primary hyperlipidemia. , 2013, Cardiovascular therapeutics.

[18]  S. Shekarforoush,et al.  Effects of atorvastatin on the hypertension-induced oxidative stress in the rat brain. , 2013, Iranian biomedical journal.

[19]  D. Djuric,et al.  23. Anxiety-related behavior in adult rats after acute homocysteine thiolactone treatment , 2013, Clinical Neurophysiology.

[20]  A. Curnis,et al.  When should we use nitrates in congestive heart failure? , 2013, Cardiovascular therapeutics.

[21]  E. Ulupınar,et al.  The effect of simvastatin treatment on behavioral parameters, cognitive performance, and hippocampal morphology in rats fed a standard or a high-fat diet , 2012, Behavioural pharmacology.

[22]  A. Viggiano,et al.  Methionine-enriched diet decreases hippocampal antioxidant defences and impairs spontaneous behaviour and long-term potentiation in rats , 2012, Brain Research.

[23]  M. Weiner,et al.  Relationship between serum homocysteine levels and depressive symptoms: the Cooper Center Longitudinal Study. , 2012, The Journal of clinical psychiatry.

[24]  I. Hovatta,et al.  Oxidative stress in anxiety and comorbid disorders , 2010, Neuroscience Research.

[25]  S. Lakhan,et al.  Nutritional and herbal supplements for anxiety and anxiety-related disorders: systematic review , 2010, Nutrition journal.

[26]  L. Vávřová,et al.  Antioxidative enzymes and increased oxidative stress in depressive women. , 2009, Clinical biochemistry.

[27]  Hong Wang,et al.  Genetic or nutritional disorders in homocysteine or folate metabolism increase protein N‐homocysteinylation in mice , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[28]  Abderrahim Oulhaj,et al.  Homocysteine as a predictor of cognitive decline in Alzheimer's disease , 2009, International journal of geriatric psychiatry.

[29]  A. Dolga,et al.  Statins: Mechanisms of neuroprotection , 2009, Progress in Neurobiology.

[30]  J. Szemraj,et al.  Lipid peroxidation and antioxidant protection in patients during acute depressive episodes and in remission after fluoxetine treatment , 2009, Pharmacological reports : PR.

[31]  D. Yellon,et al.  Statins and cardioprotection--more than just lipid lowering? , 2009, Pharmacology & therapeutics.

[32]  T. Dwolatzky,et al.  Elevated serum homocysteine levels in male patients with PTSD , 2008, Depression and anxiety.

[33]  Nirmal Singh,et al.  Ameliorative role of Atorvastatin and Pitavastatin in L-Methionine induced vascular dementia in rats , 2008, BMC pharmacology.

[34]  F. Sellke,et al.  Atorvastatin Increases Myocardial Indices of Oxidative Stress in a Porcine Model of Hypercholesterolemia and Chronic Ischemia , 2008, Journal of cardiac surgery.

[35]  M. Atmaca,et al.  Antioxidant enzyme and malondialdehyde levels in patients with social phobia , 2008, Psychiatry Research.

[36]  S. Selek,et al.  Oxidative imbalance in obsessive compulsive disorder patients: A total evaluation of oxidant–antioxidant status , 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[37]  S. Selek,et al.  Role of Oxidative and Antioxidative Parameters in Etiopathogenesis and Prognosis of Panic Disorder , 2008, The International journal of neuroscience.

[38]  Nirmal Singh,et al.  Reversal of memory deficits by Atorvastatin and Simvastatin in rats. , 2007, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

[39]  M. Folstein,et al.  The homocysteine hypothesis of depression. , 2007, The American journal of psychiatry.

[40]  C. Luley,et al.  Effect of lipid-lowering and anti-hypertensive drugs on plasma homocysteine levels , 2007, Vascular health and risk management.

[41]  S. Selek,et al.  Adenosine deaminase, nitric oxide, superoxide dismutase, and xanthine oxidase in patients with major depression: impact of antidepressant treatment. , 2007, Archives of medical research.

[42]  M. Récasens,et al.  Anxiolytic properties of green tea polyphenol (−)-epigallocatechin gallate (EGCG) , 2006, Brain Research.

[43]  O. Doğan,et al.  Examination of free radical metabolism and antioxidant defence system elements in patients with obsessive–compulsive disorder , 2006, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[44]  Barry Halliwell,et al.  Oxidative stress and neurodegeneration: where are we now? , 2006, Journal of neurochemistry.

[45]  R. Obeid,et al.  Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia , 2006, FEBS letters.

[46]  H. Herken,et al.  Nitric oxide, adenosine deaminase, xanthine oxidase and superoxide dismutase in patients with panic disorder: alterations by antidepressant treatment , 2006, Human psychopharmacology.

[47]  M. Atmaca,et al.  Serum folate and homocysteine levels in patients with obsessive‐compulsive disorder , 2005, Psychiatry and clinical neurosciences.

[48]  J. Loscalzo,et al.  Elevated levels of homocysteine compromise blood-brain barrier integrity in mice. , 2005, Blood.

[49]  R. Banerjee,et al.  Homocysteine and redox signaling. , 2005, Antioxidants & redox signaling.

[50]  K. Chan,et al.  Long-term statin use and psychological well-being. , 2003, Journal of the American College of Cardiology.

[51]  N. D. De Santo,et al.  Homocysteine and oxidative stress , 2003, Amino Acids.

[52]  M. Wajner,et al.  In Vitro Effect of Homocysteine on Some Parameters of Oxidative Stress in Rat Hippocampus , 2003, Metabolic Brain Disease.

[53]  S. Vollset,et al.  Folate, vitamin B12, homocysteine, and the MTHFR 677C->T polymorphism in anxiety and depression: the Hordaland Homocysteine Study. , 2003, Archives of general psychiatry.

[54]  C. Belzung,et al.  The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. , 2003, European journal of pharmacology.

[55]  S. Kahler,et al.  Metabolic disorders and mental retardation , 2003, American journal of medical genetics. Part C, Seminars in medical genetics.

[56]  A. Hofman,et al.  Vitamin B12, folate, and homocysteine in depression: the Rotterdam Study. , 2002, The American journal of psychiatry.

[57]  P. Ridker,et al.  Plasma Homocysteine Concentration, Statin Therapy, and the Risk of First Acute Coronary Events , 2002, Circulation.

[58]  R. Muniyappa,et al.  Pleiotropic Effects of Statins: Lipid Reduction and Beyond , 2002 .

[59]  G. Nappi,et al.  Plasma homocysteine and l-dopa metabolism in patients with Parkinson disease. , 2001, Clinical chemistry.

[60]  M. Rudnicki,et al.  Mice deficient in methylenetetrahydrofolate reductase exhibit hyperhomocysteinemia and decreased methylation capacity, with neuropathology and aortic lipid deposition. , 2001, Human molecular genetics.

[61]  G. Hankey,et al.  Homocysteine and stroke , 2001, Current opinion in neurology.

[62]  C. Culmsee,et al.  Homocysteine Elicits a DNA Damage Response in Neurons That Promotes Apoptosis and Hypersensitivity to Excitotoxicity , 2000, The Journal of Neuroscience.

[63]  C. Gottfries,et al.  Identification of Cognitive Impairment in the Elderly: Homocysteine Is an Early Marker , 1998, Dementia and Geriatric Cognitive Disorders.

[64]  A. Williams,et al.  In vitro effect of the cysteine metabolites homocysteic acid, homocysteine and cysteic acid upon human neuronal cell lines. , 1998, Neurotoxicology.

[65]  J. Leonard,et al.  Demyelination of the brain is associated with methionine adenosyltransferase I/III deficiency. , 1996, The Journal of clinical investigation.

[66]  G. F. Weber.  The pathophysiology of reactive oxygen intermediates in the central nervous system. , 1994, Medical hypotheses.

[67]  S. Bondy,et al.  Oxygen radicals: Common mediators of neurotoxicity , 2010 .

[68]  S. File,et al.  Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: A novel test of anxiety in the rat , 1986, Pharmacology Biochemistry and Behavior.

[69]  S. File,et al.  Validation of open : closed arm entries in an elevated plus-maze as a measure of anxiety in the rat , 1985, Journal of Neuroscience Methods.

[70]  B. Toone,et al.  METHYLATION AND MOOD , 1984, The Lancet.

[71]  K. Yagi,et al.  Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. , 1979, Analytical biochemistry.

[72]  I. Fridovich,et al.  The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. , 1972, The Journal of biological chemistry.

[73]  G. Ellman,et al.  Tissue sulfhydryl groups. , 1959, Archives of biochemistry and biophysics.

[74]  I W SIZER,et al.  A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. , 1952, The Journal of biological chemistry.

[75]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[76]  H. Shrishail,et al.  Evaluation of Antidepressant activity of Simvastatin, Lovastatin andAtorvastatin in Male Swiss Mice - An Experimental Study , 2013 .

[77]  B. Kaygısız,et al.  Acute antidepressant and anxiolytic effects of simvastatin and its mechanisms in rats. , 2012, Neurosciences.

[78]  Dean P. Jones,et al.  The differential effect of statins on oxidative stress and endothelial function: atorvastatin versus pravastatin. , 2012, Journal of clinical lipidology.

[79]  S. Pemminati,et al.  Role of statins in animal models of anxiety in Normo-cholesterolemic rats , 2012 .

[80]  A. Santamaría,et al.  Homocysteine-induced brain lipid peroxidation: Effects of NMDA receptor blockade, antioxidant treatment, and nitric oxide synthase inhibition , 2009, Neurotoxicity Research.

[81]  R. Obeid,et al.  The role of hyperhomocysteinemia and B-vitamin deficiency in neurological and psychiatric diseases , 2007, Clinical chemistry and laboratory medicine.

[82]  G. Ellman.  TISSUE SULPHYDRYL GROUPS , 1959 .